KarMac takes 1st Place Poster Award at 2025 MGB GCTI Symposium

December 15, 2025

News

Our research on CAR-monocytes was recognized with the 1st Place Poster Award at the 2025 MGB GCTI Symposium. We are grateful to have our findings highlighted and to share our work with the broader gene and cell therapy community.

A first-in-class CAR-Monocyte immuno-oncology platform.

About Pipeline Founders News & Publications

Advisors Contact us

KarMac is a first-in-class CAR-Monocyte platform. We engineer immune cells to break down the biological shields around solid tumors, unlocking the immune system's full power to fight back.

KarMac takes 1st Place Poster Award at 2025 MGB GCTI Symposium

More from the archive

Dr. Jennifer Guerriero named a Cancer Research Institute (CRI) Lloyd J. Old STAR

KarMac presents at 2026 ASGCT Annual Meeting

KarMac secures 2026 MGB GCTI Chemistry, Manufacturing & Controls (CMC) Award

KarMac awarded Poster of Distinction at 2026 MGB Celebration of Science

A first-in-class CAR-Monocyte immuno-oncology platform.